Literature DB >> 1941801

Antifungal agents vs. boric acid for treating chronic mycotic vulvovaginitis.

R Jovanovic1, E Congema, H T Nguyen.   

Abstract

Ninety-two women with chronic mycotic vaginal infections were followed with microscopic examination of the vaginal discharge during prolonged therapy with antifungal agents and boric acid. A microscopic picture unique to chronic mycotic vaginitis was observed, representing the cytologic reaction of the mucous membrane to chronic yeast infection. This diagnostic tool proved extremely effective in detecting both symptomatic and residual, subclinical mycotic infection and provided a highly predictive measure of the probability of relapse. The ineffectiveness of conventional antifungal agents appeared to be the main reason for chronic mycotic infections. In contrast, boric acid was effective in curing 98% of the patients who had previously failed to respond to the most commonly used antifungal agents and was clearly indicated as the treatment of choice for prophylaxis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1941801

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  7 in total

1.  What to do with the patient with recurrent vulvovaginal candidiasis.

Authors:  J S Bingham
Journal:  Sex Transm Infect       Date:  1999-08       Impact factor: 3.519

Review 2.  Evaluation and management of vaginitis.

Authors:  P L Carr; D Felsenstein; R H Friedman
Journal:  J Gen Intern Med       Date:  1998-05       Impact factor: 5.128

3.  Clinicians' Use of Intravaginal Boric Acid Maintenance Therapy for Recurrent Vulvovaginal Candidiasis and Bacterial Vaginosis.

Authors:  Anna Powell; Khalil G Ghanem; Linda Rogers; Ashley Zinalabedini; Rebecca M Brotman; Jonathan Zenilman; Susan Tuddenham
Journal:  Sex Transm Dis       Date:  2019-12       Impact factor: 2.830

Review 4.  Boric acid vaginal suppositories: a brief review.

Authors:  S M Prutting; J D Cerveny
Journal:  Infect Dis Obstet Gynecol       Date:  1998

5.  Mitochondrial dysfunction is involved in the toxic activity of boric acid against Saprolegnia.

Authors:  Shimaa E Ali; Even Thoen; Øystein Evensen; Jannicke Wiik-Nielsen; Amr A A Gamil; Ida Skaar
Journal:  PLoS One       Date:  2014-10-29       Impact factor: 3.240

6.  BASIC study: is intravaginal boric acid non-inferior to metronidazole in symptomatic bacterial vaginosis? Study protocol for a randomized controlled trial.

Authors:  Melinda Zeron Mullins; Konia M Trouton
Journal:  Trials       Date:  2015-07-26       Impact factor: 2.279

7.  Medication counselling with sodium glucose transporter 2 inhibitor therapy.

Authors:  Sanjay Kalra; Manash P Baruah; Rakesh Sahay
Journal:  Indian J Endocrinol Metab       Date:  2014-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.